CNS Pharmaceuticals, Inc. (CNSP)
NASDAQ: CNSP · Real-Time Price · USD
2.470
+0.010 (0.41%)
At close: Apr 22, 2026, 4:00 PM EDT
2.540
+0.070 (2.83%)
After-hours: Apr 22, 2026, 6:10 PM EDT
CNS Pharmaceuticals Market Cap
CNS Pharmaceuticals has a market cap or net worth of $2 million as of April 22, 2026. Its market cap has decreased by -38.12% in one year.
Market Cap
2.00M
Enterprise Value
-4.88M
1-Year Change
-38.12%
Ranking
Category
Stock Price
$2.47
Market Cap Chart
Since November 8, 2019, CNS Pharmaceuticals's market cap has decreased from $69.92M to $2.00M, a decrease of -97.13%. That is a compound annual growth rate of -42.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 21, 2026 | 2.00M | -38.70% |
| Dec 31, 2025 | 3.26M | -52.95% |
| Dec 31, 2024 | 6.92M | 4.40% |
| Dec 29, 2023 | 6.63M | 109.26% |
| Dec 30, 2022 | 3.17M | -83.83% |
| Dec 31, 2021 | 19.60M | -51.07% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Calidi Biotherapeutics | 3.04M |
| Virax Biolabs Group | 2.99M |
| HCW Biologics | 2.94M |
| BiomX | 2.93M |
| SciSparc | 2.50M |
| Bone Biologics | 2.50M |
| Propanc Biopharma | 2.33M |
| Adial Pharmaceuticals | 2.33M |